Pfizer and BioNTech submitted a request to the U.S. Food and Drug Administration for emergency use authorization of their mRNA vaccine candidate, Pfizer CEO Albert Bourla announced on Friday.
LEGAL WARNING: All rights of the published news, photos and videos are reserved by İlke Haber Ajansı Basın Yayın San. Trade A.Ş. Under no circumstances can all or part of the news, photos and videos be used without a written contract or subscription.